“…A number of strategies have been developed for the incorporation of patient‐specific gene prioritization information. The information may come from various biomedical ontologies, including human‐specific ontologies, like HPO (Köhler et al, ), Disease Ontology (DO, Schriml et al, ), Gene Ontology (GO, Blake et al, ; such as used in Phevor; Singleton et al, ) and other model organism‐specific ontologies, such as Mammalian Phenotype Ontology (MPO, Smith & Eppig, ), Zebrafish Phenotype Ontology (ZPO, van Slyke, Bradford, Westerfield, & Haendel, ; used in Exomiser; Smedley et al, ). Several computational tools leverage gene‐disease‐phenotype relationships and phenotype information, for instance, phenolyzer (Yang, Robinson, & Wang, ) and Phenotype Driven Ranking (PDR, Krämer, Shah, Rebres, Tang, & Richards, ).…”